Outcomes of patients with chronic heart failure and iron deficiency treated with intravenous iron: A meta-analysis

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 13, Issue 1, 2013, Pages 35-44

  Kapoor, Mahim ^a   Schleinitz, Mark D ^a   Gemignani, Anthony ^a,b   Wu, Wen Chih ^a,b  

^a BROWN UNIVERSITY   (United States)

^b PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anemia; Chronic heart failure; EPO; Erythropoietin; Heart failure; Intravenous iron; Iron deficiency

Indexed keywords

C REACTIVE PROTEIN; FERRIC CARBOXYMALTOSE; IRON;

ARTERIAL PRESSURE; ARTICLE; DATA EXTRACTION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; HYPERFERRITINEMIA; HYPOTENSION; IRON DEFICIENCY; LITERATURE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; SENSITIVITY ANALYSIS; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, INTRAVENOUS; ANEMIA, IRON-DEFICIENCY; ERYTHROPOIETIN; HEART FAILURE; HUMANS; IRON; TREATMENT OUTCOME;

EID: 84876743344     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871529X11313010004     Document Type: Article

References (35)

1. Hunt, S.A.; Abraham, W.T.; Chin, M.H.; Feldman, A.M.; Francis, G.S.; Ganiats, T.G.; et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J. Am. Coll. Cardiol., 2009, 53(15), e1-e90.
2. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al.; ESC Committee for Practice Guidelines, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J., 2008 29(19), 2388-2442.
3. McCullough, P.A.; Philbin, E.F.; Spertus, J.A.; Kaatz, S.; Sandberg, K.R.; Weaver, W.D. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J. Am. Coll Cardiol., 2002, 39(1), 60-69.
4. Horwich, T.B.; Fonarow, G.C.; Hamilton, M.A.; MacLellan, W.R.; Borenstein, J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J. Am. Coll Cardiol., 2002, 39(11), 1780-1786.
5. Mozaffarian, D.; Nye, R.; Levy, W.C. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J. Am. Coll Cardiol., 2003, 41(11), 1933-1939.
6. Broudulin-Nadzieja, L.; Banasiak, W.; Polonski, L.; Fillippatus, G.; McMurray, J.J.; Anker, S.D.; Ponikowski, P. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J., 2010, 31(15), 1872-1880.
7. Drakos, S.G.; Anastasiou-Nana, M.I.; Malliaras, K.G.; Nanas, J.N. Anemia in Chronic Heart Failure. Congest Heart Fail., 2009, 15, 87-92.
8. Opasich, C.; Cazzola, M.; Scelsi, L.; De Feo, S.; Bosimini, E.; Lagioia, R.; Febo, O.; Ferrari, R.; Fucili, A.; Moratti, R.; Tra-marin, R.; Tavazzi, L. Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur. Heart J., 2005, 26, 2232-2237.
9. Okonko, D.O.; Grzeslo, A.; Witkowski, T.; Mandal, A.K.; Slater, R.M.; Roughton, M.; Foldes, G.; Thum, T.; Majda, J.; Banasiak W.; Missouris, C.G.; Poole-Wilson, P.A.; Anker, S.D.; Ponikowski, P. Effect of Intravenous Iron Sucrose on Exercise Tolerance in Anemic and Nonanemic Patients With Symptomatic Chronic Heart Failure and Iron Deficiency (FERRIC-HF). J. Am. Coll. Cardiol., 2008, 51,103-112.
10. Brownlie, T.; Utermohlen, V.; Hinton, P.S.; Haas, J.D. Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am. J. Clin. Nutr., 2004, 79(3), 437-443.
11. Davies, K.J.; Maguire, J.J.; Brooks, G.A.; Dallman, P.R.; Packer, L. Muscle mitochondrial bioenergetics, oxygen supply, and work capacity during dietary iron deficiency and repletion. Am. J. Physiol., 1982, 242(6), E418-E427.
12. Silverberg, D.S.; Wexler, D.; Blum, M.; Keren, G.; Sheps, D.; Leibovitch, E.; et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J. Am. Coll. Cardiol., 2000, 35(7), 1737-1744.
13. Comin-Colet, J.; Ruiz, S.; Cladellas, M.; Rizzo, M.; Torres, A.; Bruguera, J. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence of neurohormonal activiation and clinical outcomes. J. Card. Fail., 2009, 15(9), 727-735.
14. Bolger, A.P.; Bartlett, F.R.; Penston, H.S.; O'Leary, J.; Pollock, N.; Kaprielian, R.; et al. Intravenous Iron alone for the treatment of anemia in Patients with Chronic Heart Failure. J. Am. Coll. Cardiol., 2006, 48, 1225-1227.
15. Usmanov, R.I.; Zueva, E.B.; Silverberg, D.S.; Shaked, M. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency. J. Nephrol., 2008, 21, 236-242.
16. Silverberg, D.S.; Wexler, D.; Blum, M.; Tchebiner, J.Z.; Sheps, D.; Keren, G.; Schwartz, D.; Baruch, R.; Yachnin, T.; Shaked, M.; Schwartz, I.; Steinbruch, S.; Iaina, A. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol. Dial. Transplant, 2003, 19, 141-146.
17. Toblli, J.E.; Lombrana, A.; Duarte, P.; Di Gennaro F. Intravenous iron reduced NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J. Am. Coll Cardiol., 2007, 50(17),1657-1665.
18. Silverberg, D.S.; Wexler, D.; Sheps, D.; Blum, M.; Keren, G.; Baruch, R.; Schwartz, D.; Yachnin, T.; Steinbruch, S.; Shapira, I.; Laniado, S.; Iaina, A. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized, controlled study. J. Am. Coll. Cardiol., 2001, 37(7), 1775-1780.
19. Anker, S.D.; Comin-Colet, J.; Filippatos, G.; Willenheimer, R.; Dickstein, K.; Drexler, H.; Lüscher, T.F.; Bart, B.; Banasiak, W.; Niegowska, J.; Kirwan, B.A.; Mori, C.; von Eisenhart Rothe, B.; Pocock, S.J.; Poole-Wilson, P.A.; Ponikowski, P.; FAIR-HF Trial Investigators. (FAIR-HF) Ferric carboxymaltose in patients with heart failure and iron deficiency. N. Engl. J. Med., 2009, 361(25), 2436-2448. Epub 2009 Nov 17.
20. Pubmed Home. Accessed on-line on June 5, 2010 at: http://www.pubmed.gov.
21. Home - Clinicaltrials.gov. Accessed on line on June 5, 2010 at: http://www.clinicaltrials.gov.
22. The Cochrane Library. Accessed on-line on June 5, 2010 at: http://www.mrw.interscience.wiley.com/cochrane/cochrane_clcentral_articles_fs.html.
23. Rector, T.S.; Cohn, J.N. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am. Heart J., 1992, 124,1017-1025.
24. Rector, T.S.; Kubo, S.H.; Cohn, J.N. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am. J. Cardiol., 1993, 71,1106-1107.
25. Green, C.P.; Porter, C.B.; Bresnahan XX, Spertus J.A. Development and evaluation of the Kansas City Cardiomyopathy questionnaire: a new health status measure for heart failure. J. Am. Coll. Cardiol., 2000, 35, 1245-1255.
26. Higgins, J.P.T.; Deeks, J.J.; Altman, D.G.; (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
27. DerSimonian, R.; Laird, N. Meta-analysis in clinical trials. Controlled Clin. Trials, 1986, 7, 177-188.
28. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
29. Al-Ahmad, A.; Rand, W.M.; Manjunath, G.; Konstam, M.A.; Salem, D.N.; Levey, A.S.; et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J. Am. Coll. Cardiol., 2001, 38, 955-962.
30. Mitchell, J.E. Emerging role of anemia in heart failure. Am. J. Cardiol., 2007, 99(6B), 15D-20D.
31. Nanas, J.N.; Matsouka, C.; Karageorgopoulous, D.; Leonti, A.; Tsolakis, E.; Drakos, S.G.; et al. Etiology of anemia in patients with advanced heart failure. J. Am. Coll Cardiol., 2006, 48, 2485-2489.
32. Means, R.T.; Advances in the anemia of chronic disease. Int. J. Hematol., 1999, 70(1), 7-12.
33. Clark, A.L.; Volterrani, M.; Piepoli, M.; Coats, A.J. Factors which alter the relationship between ventilation and carbon dioxide production during exercise in normal subjects. Eur. J. Appl. Physiol. Occup. Physiol., 1996, 73(1-2), 144-148.
34. Massie, B.M.; Conway, M.; Rajagopalan, B.; Yonge, R.; Frostick, S.; Ledingham, J.; Sleight, P.; Radda, G. Skeletal muscles metabolism during exercise under ischemic condtions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. Circulation, 1988, 78, 320-326.
35. Jin, B.; Luo, X.; Lin, H.; Li, J.; Shi, H. A meta-analysis of erythropoiesis-stimulating agents in anaemic patients with chronic heart failure. Eur. J. Heart Fail., 2010, 12(3), 249-253.